DJIA 17,668.35 -61.76 -0.35%
NASDAQ 4,994.36 -14.85 -0.30%
S&P 500 2,069.29 -7.49 -0.36%
market minute promo

ImmunoGen (NASDAQ: IMGN)

company name or ticker

Immunogen (IMGN) Stock Gains Today After Selling Kadcyla Royalty Rights for $200 Million

Why ImmunoGen Inc. is Skyrocketing Today

ImmunoGen Inc. has sold royalty rights in Kadcyla to TPG Special Situations Partners.

Immunogen (IMGN) Strong On High Relative Volume Today

ImmunoGen: Investors Shouldn't Read Too Much Into The Takeda Deal

Perilous Reversal Stock: Immunogen (IMGN)

Health Care Sector Update for 03/23/2015: IMGN,CAPN,MEIP

Why ImmunoGen Inc. is Soaring Higher Today

Takeda Pharmaceutical has licensed ImmunoGen's antibody-drug conjugate technology.

ICYMI: Pharmaceutical Stocks Are Moving Big On Monday

ImmunoGen (IMGN) Stock Gains Today on Japanese Licensing Agreement

Morning Market Gainers

See More Articles...